Alexandra N. De Leo

Alexandra De Leo practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Alexandra De Leo's NPI, 1114422482, was assigned on March 28, 2018. Alexandra De Leo graduated from University Of Florida College Of Medicine in 2018. Alexandra De Leo holds Florida license ME163729.

Alexandra De Leo's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Alexandra De Leo's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexandra De Leo practices. Vendor and product names are available with a free account.

Radiation oncology is Alexandra De Leo's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Alexandra De Leo is board certified in radiation oncology by the American Board of Radiology. Alexandra De Leo is licensed in Florida.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation and lung cancer radiation among the conditions Alexandra De Leo treats.

CMS data shows 1,153 Medicare services from Alexandra De Leo across 15 procedure codes in 2024, for 155 Medicare patients. Medicare paid $86,268 for them.

CMS counts 155 Medicare patients who saw Alexandra De Leo in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alexandra De Leo's median patient age at 73, with 51% women.

In 2024, Alexandra De Leo wrote 78 Medicare Part D claims for 38 patients. 99% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $39 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Alexandra De Leo for performance year 2024, reported through an alternative payment model (APM). Alexandra De Leo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexandra De Leo as offering telehealth.

Dmand AI links 20 papers to Alexandra De Leo, published from 2019 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Radiosurgery, Radiotherapy Dosage and Larynx. Alexandra De Leo has published most often in Pract Radiat Oncol. Alexandra De Leo's most frequent co-authors are Robert J. Amdur, MD, Roi Dagan, MD and William M. Mendenhall, MD.

CMS Open Payments shows 1 general payment to Alexandra De Leo from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $17.

Alexandra De Leo graduated from University Of Florida College Of Medicine in 2018.

Alexandra De Leo is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.